about
Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery.The application of in vitro methods to safety pharmacology.The Phosphodiesterase 10A Inhibitor PF-2545920 Enhances Hippocampal Excitability and Seizure Activity Involving the Upregulation of GluA1 and NR2A in Post-synaptic Densities.1-cyclohexyl-x-methoxybenzene derivatives, novel psychoactive substances seized on the internet market. Synthesis and in vivo pharmacological studies in mice.Pharmaco-toxicological effects of the novel third-generation fluorinate synthetic cannabinoids, 5F-ADBINACA, AB-FUBINACA, and STS-135 in mice. In vitro and in vivo studies.Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on "tetrad", sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies.
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
New perspectives in CNS safety pharmacology.
@ast
New perspectives in CNS safety pharmacology.
@en
New perspectives in CNS safety pharmacology.
@nl
type
label
New perspectives in CNS safety pharmacology.
@ast
New perspectives in CNS safety pharmacology.
@en
New perspectives in CNS safety pharmacology.
@nl
prefLabel
New perspectives in CNS safety pharmacology.
@ast
New perspectives in CNS safety pharmacology.
@en
New perspectives in CNS safety pharmacology.
@nl
P2093
P2860
P1476
New perspectives in CNS safety pharmacology.
@en
P2093
Martine Lemaire
Niklaus Dürmüller
Roger D Porsolt
Sylvain Roux
P2860
P304
P356
10.1046/J.1472-8206.2002.00061.X
P577
2002-06-01T00:00:00Z